期刊文献+

组织多普勒指导心脏再同步治疗后参数优化的疗效观察 被引量:1

Effect of pacing parameter optimization in cardiac resynchronization therapy
下载PDF
导出
摘要 目的:观察组织多普勒指导参数优化是否可以提高心脏再同步化治疗(CRT)的疗效。方法:对23例行CRT术后左室收缩末容积改善<10%的慢性心力衰竭患者,以达到最佳疗效为目的,在超声指导下优化房室间期、室间间期,观察优化前、优化后即刻及优化后3个月患者运动耐量及超声参数的改善情况。结果:患者优化后即刻左室充盈时间(LVFT)从(365±153)ms升至(433±109)ms,二尖瓣反流由(8.62±4.75)cm2减少至(5.43±3.96)cm2;左室内各室壁收缩期达峰时间标准差(Ts-SD-12)从(47.6±18.7)ms减少至(32.2±17.8)ms,左室流出道速度时间积分(VTILVOT)由(21.6±12.0)cm/s上升至(28.1±5.2)cm/s;优化后3个月运动耐量明显提高,6min步行距离由优化前(322.49±24.36)m增加到(415.34±63.35)m,左室射血分数(LVEF)由优化前(0.26±0.09)增加到(0.37±0.15)。结论:CRT术后行组织多普勒指导下个体化参数优化,是提高CRT疗效的一种有效手段。 Objective.To observe the effect of parameter optimization in cardiac resynchronization therapy (CRT) using ultrasound cardiographs. Methods. Twenty--three heart failure patients undergoing CRT were involved. Pacing parameters were optimized by ultrasound cardiographs, the exercise tolerance and ultrasound parameters before optimization, right after optimization and 3 months after optimization were recorded and compared. Results. After optimization, left ventricular filling time (LVFT) was increased from (365±153) ms to (433±109) ms,mitral reflux (MR) was decreased from (8.62±4.75) cm^2 to (5.43±3.96) cm^2 ,standard deviation of time to regional peak systolic velocity (Ts-SD--12) was decreased from (47.6±18.7) ms to (32.2±17.8) ms, and left ventricular outflow tract velocity time integral (VTILvoT) was increased from (21.6±12.0) cm/s to (28.1±5.2) cm/s.Three months after optimization, the 6--minute walk distance was increased from (322.49±24.36) m to (415.34±63.35) re,and left ven- tricular eject fraction (LVEF) was increased from (0.26±0.09) to (0.37±0.15). Conclusion. Pacing parameter optimization provides major hemodynamic benefits and the individualized settings using ultra-sound cardiographs are effective methods.
出处 《西北国防医学杂志》 CAS 2015年第6期351-354,共4页 Medical Journal of National Defending Forces in Northwest China
基金 陕西省社会发展科技攻关基金资助项目(2014K11-03-01-04)
关键词 慢性心力衰竭 心脏再同步治疗 超声心动图 参数优化 chronic heart failure, cardiac resynchronization therapy, ultrasound cardiograph, pacing parameter optimization
  • 相关文献

参考文献16

  • 1AbrahamW T,Fisher W G,Smith A a/.Cardiac re-synchronization in chronic heart failure [ J 3. N Engl JMed,2002,346(24) :1845-1853.
  • 2BristowM R,Saxon L A,Boehmer J9et al.Cardiac resyn-chronization therapy with or without an implantable de-fibrillator in advanced chronic heart failure [J].N Engl JMed,2004,350(21) :2140-2150.
  • 3ClelandJ G,Daubert J C,Erdmann E,et al.The effect ofcardiac resynchronization on morbidity and mortality inheart failure [J].N Engl J Med,2005, 352 (15) : 1539 -1549.
  • 4郭继鸿.深入认识心脏再同步化治疗心力衰竭的机制[J].中国心脏起搏与心电生理杂志,2006,20(4):283-284. 被引量:62
  • 5LipoldovaJ, Ozabalova E, Meluzin J,et al.Usefulness ofleft ventricle dyssynchrony assessment before cardiac re-synchronization implantation [J]. Biomed Pap Med FacUniv Palacky Olomouc Czech Repub,2010,154(1) : 39 -46.
  • 6BaxJ J,Bleeker G B,Marwick T Htet al.Left ventriculardyssynchrony predicts response and prognosis after cardi-ac resynchronization therapy[J].J Am Coll Cardiol,2004,44(9):1834-1840.
  • 7Gras D, Gupta M S,Boulogne E, et aL Optimization ofAV and VV delays in the real-world CRT patient popu-lation: an international survey on current clinical practice[J].PACE, 2009,32(Suppl):s236-s239.
  • 8陈泗林,林纯莹,费洪文,刘烈,陈东骊,梁远红,吴书林.心脏再同步治疗起搏参数优化对血流动力学的影响及随访[J].中华心律失常学杂志,2009,13(2):133-136. 被引量:6
  • 9BaxJ J, Abraham T,Barold S S,et al.Cardiac resynchro-nization therapy: parti - issues before device implanta-tion[J].J Am Coll Cardiol,2005,46(12) :2153-2167.
  • 10lnoueN,Ishikawa T,Sumita S,et al.Long-term follow-up of atrioventricular delay optimization in patientswith biventricular pacing[J].Circ J,2005,69 (2) : 201 -204.

二级参考文献23

  • 1王建安,何红,杨倩,盛夏,孙勇,蒋晨阳,周斌全,董樑.双心室优化程序起搏治疗充血性心力衰竭及短期随访结果[J].中华心律失常学杂志,2005,9(3):218-222. 被引量:22
  • 2牛红霞,华伟,张澍,孙欣,王方正,陈柯萍,陈新.心脏再同步治疗术后房室延迟和室间延迟参数的优化[J].中华心律失常学杂志,2005,9(6):409-412. 被引量:12
  • 3陈泗林,林纯莹,杨平珍,詹贤章,吴书林.心脏再同步治疗慢性心力衰竭的中远期疗效观察[J].中华心律失常学杂志,2006,10(2):108-110. 被引量:9
  • 4Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European bociety ol Cardiology. Developed m collaboration with the European Heart Rhythm Association. Europace ,2007,9:959-998.
  • 5Poreiani MC, Dondina C, Macioce R, et al. Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail ,2006,12:715-719.
  • 6Ha JW, Lee HC, Kang ES, et al. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus:implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart,2007,93 : 1571-1576.
  • 7Cazeau S,Leclercq C,Lavergne T,et al.Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.N Engl J Med,2001,344:873-880.
  • 8Auricchio A,Stellbrink C,Sack S.Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol,2002,39:2026-2033.
  • 9Abraham WT,Fisher WG,Smith AL,et al.Cardiac resynchronization in chronic heart failure.N Engl J Med,2002,346:1845-1853.
  • 10Daubert JC,Linde C,Cazeau S,et al.Clinical effects of biventricular pacing in patients with severe heart failure and chronic atrial fibrillation:a results from the Multisite Stimulation in Cardiomyopathy(MUSTIC)study group Ⅱ.Circulation,2000,102:3349A.

共引文献90

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部